"L-lysine aescinat": ntuziaka maka ojiji na nzaghachi

Emegharị-agụghị oké na orunótu nke mgbagwoju adụ anụ ahụ edema, nākpasu-enwe nsogbu ọbara esenyịn ruo n'ókè usoro, na-esonyere mgbu - nnọọ ihe ịma aka maka ọgwụ ụlọ ọrụ. Unan nke ụdị ndị kasị-abụkarị n'ihi nke arụmọrụ na postoperative adọ ma ọ bụ n'ihi nke n'ibu mmebi nke nweekwa usoro, Ngalaba nke ụbụrụ na / ma ọ bụ ọgidigi azụ (voluminous hematoma, nsogbu nke mkpakọ fractures n'ụdị nwayọọ ọkọ na na. N.).

Quality ọgwụgwọ na oru oma mgbochi nke edema-mgbu - a "ebe nke ibu ọrụ" diuretics, corticosteroids, flavonoids, alkaloids nke ergot, na ọgwụ ewepụtara mkpụrụ nke nkịtị ịnyịnya chestnut. Na nke ikpeazụ ahụ, a mmasị pụrụ iche bụ "Lysine aescinat", analogues nke nke, n'agbanyeghị myirịta algọridim maka pharmacological-eme ihe, mgbe ụfọdụ ike na-enye ndị chọrọ ọgwụgwọ mmetụta.

Mmeghachi omume nọ n'ọrụ umi

"Lysine aescinat" ntụziaka ntuziaka classifies ka multi angioprotector. Components nke ọgwụ mkpatụ na mkpụrụ ndụ nke ahụ, belata likelihood nke nnukwu-ọnụ ọgụgụ mmepe nke mbufụt, emenyu uche nke ihe mgbu na-anabata ya ma jiri nwayọọ na ọganihu nke ozizi na anụ ahụ (aka full stop exudative Filiks).

Nke a pụta bụ na o kwere omume ekele na mgbochi nke lysosomal hydrolases na-ahụ maka cleavage ọnụego mucopolysaccharides n'ime ọbara edoghi na n'akụkụ connective anụ ahụ. Agafeghị oke hypoglycaemic mgbaàmà na a n'ozuzu na-abawanye na vaskụla ụda na ndabere nke normalisation nke ha permeability - ọ bụ a eke N'ihi nke metered eji nke a ọgwụ.

Egosi agwọ ọrịa bu n'obi

"Lysine aescinat" (ọrụ eweta ya dị ka ụdị nke a ọtụtụ ndị mejupụtara òtù triterpene saponins nke ịnyịnya chestnut) retsepturno ndinọ ma ọ bụrụ na:

• chọpụtara ụbụrụ / ọgidigi azụ arọ na oké egwu ogo ọzịza development (gụnyere mgbe irè nke ọnụnọ intracranial hematomas dechapụ);
• Ọ hụrụ na obodo ọzịza nke adụ anụ ahụ na-emetụta nweekwa usoro (ndidi ije / emega ahụ akara ụfụ, na mebiri emebi ebe nke ahu ọnọ ọbara dị na gbara gharịị mode);
• ziri ezi suspicions banyere nnukwu thrombophlebitis (ihe ahaghị nhata n'etiti ụkwụ venous mgbasa, n'ihu usugublonny edematous mkpali).

"Lysine aescinat": ntuziaka maka ojiji na-atụ aro usoro onunu ogwu

Iji nke ọgwụ na-agụnye leisurely igba ogwu n'akwara (mwube intra-dropper a machibidoro kpam kpam). The kacha kwa onunu ogwu n'ihi na ndị okenye - 5,10 ml nke nkwadebe diluted na 0,9% sodium chloride ngwọta (olu NaCl - 15-50 ml). Otú ọ dị, ikpe nke ihe iyi egwu ndụ nke onye ọrịa (na-emekarị na-aga n'ihu ụbụrụ edema) ime abawanye kwa ụbọchị uru nke ruo 20 ml n'ọrụ mgwa (nzọụkwụ abụọ ka awa 24, 10 ml ọ bụla). Reserve dose - 25 ml / ụbọchị.

Ọrịa-ụmụ "Lysine aescinat" ntụziaka ekpebi ịbanye dị otú ahụ quantities:

• afọ nwa 1-5 afọ: 0,22 mg kwa kilogram nke ahu aro;
• afọ 5-10 afọ: 0,18 mg / n'arọ;
• afọ 10-15 afọ: 0,15 mg ọgwụ kwa n'arọ;
• afọ 15-18 afọ: 0,12 ml / n'arọ.

Nkwadebe nke nọ n'ọrụ solution, diluting na agwọ ọrịa i.e. nke sodium chloride ga-mere ozugbo n'ihu were. The ngụkọta ogologo ọgwụgwọ ekwesịghị gafere 8 ụbọchị (ọnụego nwere ike belata ka ụbọchị abụọ ma ọ bụrụ na dọkịta na-ekpebi na ọrịa na-arịa ka Nọsi'ike n'ihu kpọmkwem oge).

Results si Clinical ọmụmụ

"Lysine aescinat 'ntuziaka maka ojiji na-positioned dị ka a ọgwụ, clinically nwalere na gosiri elu arụmọrụ na-alụso edema nke dị iche iche ọdịdị nke si malite. Karịsịa, ọrịa na-akpasasị uche akpụ ụbụrụ mgbe ochichi nke ọgwụ site IV enwere a ịrịba Mbelata ke mbufụt ebe. Na mberede dịgasị iche iche na ọzịza nke ihe owuwu: kwụsịrị asụla undamaged òkè na aka mee ngwangwa stabilization nke mgbali n'ime cranium. Ọ na-ahụ kwuru na-adọ injections "Lysine aescinat", mere n'ụdị a ezigbo deceleration nke ọgwụ infusion, mgbe mgbe, na-egbochi mmepe nke n'elu-e kwuru ndapụta na bara uru ndidi ahụ ike.

Suppression nke mkpali Ibọrọ na mbụ nkebi na iji gbochie ọzịza olu na-apụta ìhè na-akpali akpali ọtọ ọrụ nke ụbụrụ, ya bụ, na-ebelata recourse akwara endings.

Special Ọnọdụ nke Iji

N'agbanyeghị eziokwu na njikere nke "Lysine aescinat" comments mkpa ọkachamara na-ukwuu n'ime mma, pụrụ ịdabere na ozi dị ka mmeghachi omume nke nọ n'ọrụ Efrata ka nke nwa ebu n'afọ n'oge ime abụghị (a ọnọdụ yiri nke ahụ na ara ụmụ ọhụrụ). Ya mere nye iwu ọgwụ dị otú ahụ ikpe na-adịghị atụ aro.

Ke adianade do, uche pụrụ iche na e kwesịrị ọrịa na a nchoputa nke "hepatocholecystitis" - aescinat-arụ ọrụ nke a eke mkpali maka transaminases na imeju nwere ike ubé mara. Otú ọ dị, na enweghị ndị ọzọ pathologies kwuru ọrịa - ọ bụghị a mere discontinuation nke ọgwụ.

Mmetụta na contraindications

E wezụga ime na lactation maka ọgwụ "Lysine aescinat" ntụziaka ntuziaka ọgwụ na-eweta dị otú ahụ mgbochi:

• idiosyncrasy mmiri;
• nnukwu gbasara akụrụ odida ;
• Nsogbu ndị siri imeju;
• ọbara ọgbụgba (ọnyá ma ọ bụ ụdị ndị ọzọ nke ozize nke akụkụ na anụ ahụ).

Isiokwu na n'elu ọnọdụ, nfụkasị Jeremaya ọgwụ bụ obere. Ma ha na-agaghị ekwe:

• akpụkpọ itching, aṅụ, agụmakwụkwọ egbuke "ime ihiere" na ihu;
• Ụjọ System: tremor, nwetụ na ụfụ, nnukwu undamped isi ọwụwa, na-ada mbà;
• Gi: ọgbụgbọ, mgbe ụfọdụ - afọ ọsịsa na vomiting;
• biliary usoro na imeju: a na-adịghị adịte abawanye na ọrụ nke transaminases na bilirubin;
• ọbara arịa na obi, hypotension na ọbara mgbali elu, arrhythmia;
• akụkụ okuku ume na usoro: dyspnea, ike akọrọ ụkwara.

Ọtụtụ mgbe, mmetụta nke agụghị oké kwuru na, na-eme ka o sie ike ịchọpụta allergies. Ka ihe atụ, adịghị ike ma ọ bụ okpomọkụ nwere ike na-aghọta na-dị ka a n'ihi nke na-anata igba ogwu n'akwara ọgwụ, na dị ka a N'ihi ya nke ndị nkịtị oyi.

Ọdịdị nke mmekọrịta ọgwụ ndị ọzọ

"Lysine aescinat" (Ibọrọ nke ọrịa banyere ọgwụ, dị ka a na-achị, na-ebelata ka isiokwu nke nsogbu na nweekwa usoro, ebe ọ bụ iji chọpụta ihe ndị ọgwụgwọ utịp ke ụbụrụ unan, n'ihi na criticality nke ọnọdụ, ha nwere ike ghara) itinye mmanya-nwere ogige. Ya mere, iji họrọ ọgwụ maka imekotaotuugbo ojiji na a N'ezie nke ọgwụ dị mkpa na elu ịkpachara anya (alkaloids ike neutralize ifịk umi).

Kpọtụrụ aescinat na aminoglycosides bụ ekwesighi. Ihe kpatara idu ke ụba toxicity nke reagents. Ọnụnọ nke anticoagulants na Ntụziaka akpali ịtụleghachi ọgwụ onunu ogwu ka ibelata kwa norm. Ma mkpakọrịta na analgesics na antimicrobials-aga nke ọma (mgbochi mkpali Njirimara aescinat ike megide ndabere nke enweghị ọzọ ibu na akụkụ na usoro).

Hapụ ụdị na nkọwa

Dị ka onye nnọchiteanya otu angioprotectors, ọgwụ «L-lysine aescinat" Fim nke bụ na mgbe ụfọdụ nke onye na-adịghị na-egosipụta ezi picture nke ọnọdụ, ọ atara dị ka a doro anya, colorless ngwọta. Na 1 ml nke mmiri mmiri gụnyere 0,001 g nke nọ n'ọrụ umi. The ọrụ nke ngwa components kenyere propylene glycol, ethyl mmanya na-akpan kwadebere (ọgwụ) mmiri.

A nkenke nke ọzọ preparations

Trade aha maka ọgwụ kọwara - "Lysine aescinat".

Analogs nke yiri pharmacological edinam ndị dị ka ndị:

• "Furosemide" (mbadamba / ngwọta) - akara mgbu-edematous na butere n'aka ọrịa na nke obi usoro, mkpochapu swellings na saịtị ụbụrụ / ọgidigi azụ (hematoma n'ibu ọdịdị nke si), mmetuta nke diuresis, etc ..
• "Hypothiazid" (mbadamba) - na edema iwe na congenital obi ọdịda, imeju, ọbara mgbali.
• "Valusal" (mbadamba / capsules / ude / ngwọta) - maka containment na neutralization nweekwa degenerative Filiks enyemaka nke postoperative mgbu, wdg ...

"Lysine aescinat": reviews nke dọkịta na ndị ọrịa

Edema na ọzịza nke anụ ahụ nke na-hemispheric ụbụrụ anụ - àmà na-egosi oké traumatic mmerụ ahụ n'ụbụrụ. Dị ka ndị ọkachamara, na ọnọdụ dị otú ahụ a bughi mgbanwe nke cortical ebe, nke gụnyere nkwarụ ma ọ bụ ọnwụ - a okwu nke awa, mgbe ụfọdụ, nkeji. N'ihi na stabilization na-emekarị rụrụ akpịrị ịkpọ nkụ ọgwụ. Otú ọ dị, corticosteroids, na saluretiki osmotiki - kasị nkịtị "ngwaọrụ" mmetụta - ọtụtụ mgbe akpasu mmetụta ma ọ bụ adịghị ziri ezi nyere ha olileanya.

Na echiche nke na-eme neurosurgeons, onye ọzọ gị n'ụlọnga ga-atụle "Lysine aescinat" (ntuziaka, ezigbo ndị ọkachamara na mkpa nuances banyere ụzọ nke ojiji nke ọgwụ, e gosiri n'elu). N'adịghị ka analogue, ntụtụ adịghị akpata oké egwu nsogbu n'ụzọ ziri ezi see lekwasịrị, si otú enye akara nke Ọnọdụ nke ozizi (olu ebenata ụbụrụ / ọgidigi azụ ọzịza).